Clinical Trials Logo

Clinical Trial Summary

Dietary protein intake is vital for the maintenance of skeletal muscle mass and health. The production of animal-based proteins sources is associated with growing environmental and ethical challenges. As such, sustainable alternatives are needed. Algae are sustainably produced high-protein sources and it is predicted that algae will become one of the most consumed proteins in the next decades. However, the effects of algae on the stimulation of muscle mass growth are unknown. Therefore, we aim to assess the rate of digestion and absorption, and the effects on muscle growth of two types of algae (spirulina and chlorella) when compared to a sustainable non-animal derived fungal reference protein (mycoprotein), a source known to elicit a robust anabolic response.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05016557
Study type Interventional
Source University of Exeter
Contact
Status Completed
Phase N/A
Start date December 19, 2020
Completion date June 24, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04241497 - Home-based Exercise Training in Patients With Pulmonary Arterial Hypertension: Effect on Skeletal Muscular Function and Metabolism N/A
Completed NCT06129513 - The Effect of a Plant-blend Protein Isolate on Post-exercise Myofibrillar Protein Synthesis N/A